z-logo
open-access-imgOpen Access
NESH protein expression switches to the adverse effect of imatinib mesylate
Author(s) -
Matsuda Satoru,
Ichigotani Yasukatu,
Okumura Naoko,
Yoshida Hitomi,
Kajiya Yuka,
Kitagishi Yasuko,
Shirafuji Naoki
Publication year - 2008
Publication title -
molecular oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.332
H-Index - 88
eISSN - 1878-0261
pISSN - 1574-7891
DOI - 10.1016/j.molonc.2008.03.003
Subject(s) - imatinib mesylate , abl , cancer research , tyrosine kinase , imatinib , chronic myelogenous leukemia , tyrosine kinase inhibitor , chemistry , biology , microbiology and biotechnology , signal transduction , leukemia , cancer , immunology , genetics , myeloid leukemia

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom